51例原发性肝癌患者介入治疗的临床疗效观察
周爱民徐建华(南京医科大学第三附属医院放射科 211900)
【中图分类号】【文献标识码】A【文章编号】1672-5085(2012)5-0189-03
【摘要】目的探讨原发性肝癌患者介入治疗,经选择性肝动脉化疗栓塞介入治疗的方法和疗效。方法收集2008年3月—2011年3月在本科做介入治疗的51例中晚期肝癌患者的资料。所有患者皆以导管超选择插入肿瘤的供血动脉,以奥沙利铂+氟尿嘧啶+吡柔比星化疗,再以超液态碘化油、明胶海绵栓塞。结果所有病例皆成功进行了化疗和栓塞治疗。51例患者术后均进行了CT或B超随访,其中瘤体缩小20例>200%,16例>100%,12例>50%,3例缩小不明显。51例患者中,生存期5年以上者16例,3年以上20例,2年以上者12例,12个月以下者3例,其中48例患者术后症状明显减轻,%,术后无严重并发症。结论超选择肝动脉化疗栓塞术是治疗原发性肝癌患者的安全、有效的首选方法。
【关键词】原发性肝癌介入治疗临床疗效观察
【Abstract】 Objective To explore in patients with primary hepatic carcinoma interventional therapy,percutaneous selective hepatic artery chemotherapy embolization interventional therapy method and effect. 2008 March - 2011 March methods in undergraduate do interventional therapy in 51 patients with advanced liver cancer patient information. All patients with ductal super select Insert the feeding artery of the tumor,with cisplatin plus 5-fluorouracil and mitomycin and epirubicin chemotherapy,with super liquid iodized oil,gelatin sponge embolization. Results all cases were essful; the chemotherapy and embolization in the treatment of. In 51 patients after underwent CT or B ultrasound follow-up,in which the tumor reduced in 20 cases 16 cases > 200%,100%,12 > 50%,3 cases of narrowing is not obvious. In 51 patients
,the survival period of 5 years in 16,3 years in 20 cases,2 years in 12,12 months of age in 3 c
51例原发性肝癌患者介入治疗的临床疗效观察 来自淘豆网m.daumloan.com转载请标明出处.
